[Ip-health] KEI Statement on United Nations Secretary-General's High-Level Panel on Access to Medicines Report

Zack Struver zack.struver at keionline.org
Wed Sep 14 07:03:35 PDT 2016


http://keionline.org/node/2626

KEI Statement on United Nations Secretary-General's High-Level Panel on
Access to Medicines Report

On September 14, 2016, the United Nations Secretary-General's High-Level
Panel on Access to Medicines issued its long-awaited report, which
addressed the policy incoherencies between intellectual property, trade,
human rights, innovation, and public health.

The report is available here:
http://keionline.org/sites/default/files/UNSG_HLP_A2M_Report_FINAL_Sept_2016.pdf

We will provide a more detailed comment later today.

Statement by James Love, the Director of Knowledge Ecology International:

"The UN panel has recommended governments embrace new ways to pay for
innovation and to increase access to health technologies. Under the current
system, we rely too much on high drug prices to incentivize innovation, and
this reduces access. The most important recommendations from the UN experts
is to delink the cost of R&D from the prices of drugs. You cannot rely upon
high drug prices to finance R&D without harming patients and creating
unequal access. Policy coherence means making innovation and access happen
at the same time. Delinkage is key to policy coherence.

"The panel makes a number of other helpful recommendations, such as those
endorsing more transparency of the economics of drug development and
marketing, the elimination of pressure on countries that use compulsory
licenses to curb high drug prices, and encouraging companies to license
patents to generic competitors in developing countries. All of these
measures are important and useful."

-- 
Zack Struver, Communications and Research Associate
Knowledge Ecology International
zack.struver at keionline.org
Twitter: @zstruver <https://twitter.com/zstruver>
Office: +1 (202) 332-2670 Cell: +1 (914) 582-1428
keionline.org



More information about the Ip-health mailing list